Skip to navigation bar Skip to breadcrumbs Skip to page content
Envelope icon E-mail Updates Teal square Text size:  a A A
You are here: HomeAnnouncementsAnnouncement Detail

Final Recommendation Statement: Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women

December 12, 2017The U.S. Preventive Services Task Force released today a final recommendation statement on hormone therapy for the primary prevention of chronic conditions in postmenopausal women. The Task Force recommends against hormone therapy for preventing chronic conditions in women who have gone through menopause, as the benefits do not outweigh the harms. To view the recommendation and the evidence on which it is based, please go to https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/menopausal-hormone-therapy-preventive-medication1. The final recommendation statement can also be found in the December 12, 2017 online issue of JAMA.

Current as of: October 2018

Internet Citation: Final Recommendation Statement: Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women. U.S. Preventive Services Task Force. December 2017.
https://www.uspreventiveservicestaskforce.org/Announcements/News/Item/final-recommendation-statement-hormone-therapy-for-the-primary-prevention-of-chronic-conditions-in-postmenopausal-women

USPSTF Program Office   5600 Fishers Lane, Mail Stop 06E53A, Rockville, MD 20857